Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Share
Latest News
Featured Stories
More from Johnson & Johnson
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
On the next episode of "The Road to a Vaccine," host Lisa Ling delves into how the pandemic is affecting parents, children and school staff. We sat down with one of the upcoming guests, school nurse Robin Cogan, to find out the most pressing questions on her mind—and those of moms and dads.
Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.
